Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merle L Diamond

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Headache|February 1, 2008
Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migrainesMerle L Diamond, Roger K Cady, Lian Mao, et al.
Obstetrics and Gynecology|June 24, 2009
Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trialsLisa K Mannix, Vincent T Martin, Roger K Cady, et al.
Headache|September 22, 2021
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headacheMichael J Marmura, Hans-Christoph Diener, Robert P Cowan, et al.
Headache|December 14, 2020
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2Hans-Christoph Diener, Michael J Marmura, Stewart J Tepper, et al.
Headache|April 21, 2007
Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS)Frederick G Freitag, Gary Finlayson, Alan M Rapoport, et al.
Headache|April 28, 2011
Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomesRoger K Cady, Merle L Diamond, Michael P Diamond, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Headache|February 1, 2008
Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migrainesMerle L Diamond, Roger K Cady, Lian Mao, et al.
Obstetrics and Gynecology|June 24, 2009
Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trialsLisa K Mannix, Vincent T Martin, Roger K Cady, et al.
Headache|September 22, 2021
Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headacheMichael J Marmura, Hans-Christoph Diener, Robert P Cowan, et al.
Headache|December 14, 2020
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2Hans-Christoph Diener, Michael J Marmura, Stewart J Tepper, et al.
Headache|April 21, 2007
Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS)Frederick G Freitag, Gary Finlayson, Alan M Rapoport, et al.
Headache|April 28, 2011
Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomesRoger K Cady, Merle L Diamond, Michael P Diamond, et al.
Pageof 2